Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination therapy with glutaminase inhibitors

Combination therapy with glutaminase inhibitors

US Patent 10195197 · Granted Feb 5, 2019

Estimated economic value: $2,763,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Arginase inhibitor combination therapies2022
Combination therapy with glutaminase inhibitors and immuno-oncology agents2021
Combination therapy with glutaminase inhibitors and immuno-oncology agents2021
Combination therapy with glutaminase inhibitors and immuno-oncology agents2021
Compositions and methods for inhibiting arginase activity2021
Combination therapy with peptide epoxyketones2020
Combination therapy with peptide epoxyketones2020
Compositions and methods for inhibiting arginase activity2019
Combination therapy with glutaminase inhibitors2019
Combination therapy with glutaminase inhibitors and immuno-oncology agents2019
Combination therapy with glutaminase inhibitors and immuno-oncology agents2019
Combination therapy with glutaminase inhibitors and immuno-oncology agents2019